bpc 157 fda unapproved peptide warning Understanding the Legal Risks of BPC-157 and Other Peptides – Holt Law canadian bpc 157 fda warning
Description
January 2023 28

Documentation best practice: save the fluoroscopic images or CT cross-sections to the patient record and reference them by series or frame in the procedure note

Studies suggest that BPC-157 interacts with multiple biological pathways simultaneously, which distinguishes it from many single-target peptides

Risks for IV infusions are fairly minimal, however, there is always a small risk of infection